Development and Validation of the Schedule for the Assessment of Insight in Anxiety Disorders (SAI‐A).
Saved in:
| Title: | Development and Validation of the Schedule for the Assessment of Insight in Anxiety Disorders (SAI‐A). |
|---|---|
| Authors: | Halaj, Asala (AUTHOR), Huppert, Jonathan D. (AUTHOR), Konstantakopoulos, George (AUTHOR), David, Anthony S. (AUTHOR), Liu, Xinqiao (AUTHOR) |
| Source: | Depression & Anxiety (1091-4269). 9/24/2025, Vol. 2025, p1-9. 9p. |
| Subjects: | Anxiety disorders, Psychometrics, Statistical reliability, Test validity, Diagnosis, Awareness, Personality assessment |
| Abstract: | There is a growing interest in understanding insight or illness awareness in anxiety; however, most assessment instruments were designed for psychosis. The unique features of anxiety highlight the need for tailored measures to accurately evaluate insight. The aim of this study was to develop and validate the Schedule for the Assessment of Insight in Anxiety (SAI‐A), a clinician‐rated scale for assessing insight in anxiety disorders. We interviewed 46 participants diagnosed with anxiety disorders, conducted SAI‐A interviews, and administered self‐report measures. Using correlation and principal component analysis (PCA), we identified and assessed scale components, ensuring their reliability and consistency. The SAI‐A demonstrated acceptable psychometric properties, including convergent validity with an established self‐report measure (r = −0.39, p = 0.008) and internal consistency (Cronbach's α = 0.70). It showed moderate to strong agreement, interrater reliability (weighted kappa = 0.53, intraclass correlation coefficient [ICC] = 0.67), and test–retest reliability (ICC = 0.65). Two distinct insight components emerged: awareness of disorder and need for treatment. Higher overall SAI‐A scores correlated with symptom severity and impairment (r = 0.56, r = 0.51, p < 0.001, respectively) and medication usage. The SAI‐A is a valid and reliable assessment tool, providing a comprehensive framework for understanding and addressing insight in the context of anxiety disorders. [ABSTRACT FROM AUTHOR] |
| Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | There is a growing interest in understanding insight or illness awareness in anxiety; however, most assessment instruments were designed for psychosis. The unique features of anxiety highlight the need for tailored measures to accurately evaluate insight. The aim of this study was to develop and validate the Schedule for the Assessment of Insight in Anxiety (SAI‐A), a clinician‐rated scale for assessing insight in anxiety disorders. We interviewed 46 participants diagnosed with anxiety disorders, conducted SAI‐A interviews, and administered self‐report measures. Using correlation and principal component analysis (PCA), we identified and assessed scale components, ensuring their reliability and consistency. The SAI‐A demonstrated acceptable psychometric properties, including convergent validity with an established self‐report measure (r = −0.39, p = 0.008) and internal consistency (Cronbach's α = 0.70). It showed moderate to strong agreement, interrater reliability (weighted kappa = 0.53, intraclass correlation coefficient [ICC] = 0.67), and test–retest reliability (ICC = 0.65). Two distinct insight components emerged: awareness of disorder and need for treatment. Higher overall SAI‐A scores correlated with symptom severity and impairment (r = 0.56, r = 0.51, p < 0.001, respectively) and medication usage. The SAI‐A is a valid and reliable assessment tool, providing a comprehensive framework for understanding and addressing insight in the context of anxiety disorders. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10914269 |
| DOI: | 10.1155/da/8843975 |
